Prima BioMed to Host Shareholder Briefing
(firmenpresse) - SYDNEY, AUSTRALIA -- (Marketwire) -- 05/31/12 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (Prima, the Company) advises that it will hold a shareholder briefing with the Company's CEO designate Matthew Lehman, current CEO Martin Rogers, Chairman Lucy Turnbull, and Deputy Chairman Albert Wong in Sydney, Australia, on Friday, 15 June 2012.
The briefing will provide an opportunity for Mr. Lehman to meet shareholders and deliver an update on the Company's activities.
Mr. Lehman, who is currently Prima's Chief Operating Officer, will become the Company's CEO effective 1 September 2012 (see ASX announcement of 24 May).
Friday, 15 June 2012
9:30am to 11:00am AEST (local time)
Radisson Blu Hotel Sydney
27 O'Connell St Sydney (Marble Room 2 and 3)
Shareholders outside Sydney will be able to access the briefing via a webcast and dial-in facility. Webcast and dial-in details will be provided on the Prima BioMed and ASX websites prior to the meeting.
Shareholders, and other interested parties, are kindly requested to RSVP to prior to the event to assist in planning the meeting. Shareholders are also encouraged to submit questions or comments via email prior to the meeting.
Prima has updated the Company Calendar section of its website to include this shareholder briefing and other relevant upcoming public presentations.
Prima BioMed is a global biotechnology company headquartered in Australia. As a leader in personalised bio-therapeutic products for cancer, Prima is dedicated to leveraging its current technology and expertise to develop innovative treatment options for patients and maximise value to shareholders. Prima's lead product is CVac™, an autologous dendritic cell product currently in clinical trials for ovarian cancer.
Australia Investor/Media:
Mr. James Moses
Mandate Corporate
+61 (0) 420 991 574
USA Investor/Media:
Ms. Kathy Galante
Burns McClellan Inc.
+1 (212) 213-0006
Europe Investor/Media:
Mr. Axel Mühlhaus
edicto GmbH
+49 (0) 69 905505-52
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 30.05.2012 - 22:07 Uhr
Sprache: Deutsch
News-ID 1119453
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SYDNEY, AUSTRALIA
Phone:
Kategorie:
Hospitals, Facilities and Providers
Anmerkungen:
Diese Pressemitteilung wurde bisher 155 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Prima BioMed to Host Shareholder Briefing
"
steht unter der journalistisch-redaktionellen Verantwortung von
Prima BioMed (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
